Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 424/144.1
Name: Drug, bio-affecting and body treating compositions > Immunoglobulin, antiserum, antibody, or antibody fragment, except conjugate or complex of the same with nonimmunoglobulin material > Monoclonal antibody or fragment thereof (i.e., produced by any cloning technology) > Binds receptor > Receptor integral to or derived from a lymphocytic or lymphocytic-like cell (e.g., nk cell, etc.)
Description: Subject matter involving a monoclonal antibody or antigen-binding fragment thereof whose antigen-binding site(s) will combine with a receptor integral to or derived from a lymphocytic or a lymphocytic-like cell.










Patents under this class:
1 2 3 4 5 6 7 8 9 10 11 12 13

Patent Number Title Of Patent Date Issued
7501123 Human G-protein chemokine receptor (CCR5) HDGNR10 Mar. 10, 2009
7498031 Therapeutic agents for inner ear disorders containing an IL-6 antagonist as an active ingredient Mar. 3, 2009
7498032 Methods for treating immune disorders or cancer with anti-CD40 antibodies Mar. 3, 2009
7495081 Framework patched anti-CD20 antibody Feb. 24, 2009
7491393 Methods of inhibiting IL-2 production by T cells by administering 7C10 and 16C10 CD80-specific antibodies Feb. 17, 2009
7491514 Reducing the immunogenicity of anti-CD20 antibodies by framework patching Feb. 17, 2009
7488804 Modified fusion molecules for treatment of allergic disease Feb. 10, 2009
7482000 Mutant Fab fragments of the chimeric 13B8.2 anti-CD4 antibody and their applications Jan. 27, 2009
7482003 Treatment for asthma with .alpha.4-specific antibodies Jan. 27, 2009
7476385 Methods of inhibiting IgE responses to thymus-dependent antigens with the anti-gp39 antibody MR1 Jan. 13, 2009
7465446 Surrogate therapeutic endpoint for anti-CTLA4-based immunotherapy of disease Dec. 16, 2008
7465464 Populations of cells that express flk-2 receptors Dec. 16, 2008
7462353 Method for the treatment of inflammatory disorders Dec. 9, 2008
7452536 Methods of treating cancer by administering antibodies to CD200 Nov. 18, 2008
7445780 Antagonistic anti-CD40 antibodies Nov. 4, 2008
7445781 Anti-CD40CR MR1 antibody Nov. 4, 2008
7445798 Populations of cells that express FLK-1 receptors Nov. 4, 2008
7438910 Therapeutic human anti-IL1-R1 monoclonal antibody Oct. 21, 2008
7438907 Human monoclonal antibodies against CD25 Oct. 21, 2008
7435803 Anti-CD20 antibodies and fusion proteins thereof and methods of use Oct. 14, 2008
7427401 Method of modulating leukemic cell and eosinphil activity with monoclonal antibodies Sep. 23, 2008
7425623 Antibody with specificity for colon cancer Sep. 16, 2008
7422745 Methods of treating cancer with .sub.v.alpha..beta..sub.3-specific antibodies Sep. 9, 2008
7422744 Methods of treating cancer with alphavbeta3-specific antibodies Sep. 9, 2008
7422739 Anti-CD20 antibodies Sep. 9, 2008
7419663 Treatment of complement-associated disorders Sep. 2, 2008
7419666 Treatment of ocular disorders Sep. 2, 2008
7396530 Method of treating granuloma annulare or sarcoid Jul. 8, 2008
7393934 Human G-protein chemokine receptor (CCR5) HDGNR10 Jul. 1, 2008
7393532 Modulation of T cell differentiation for the treatment of T helper cell mediated diseases Jul. 1, 2008
7390490 Uses of anti-CX3CR1 antibody, anti-fractalkine antibody and fractalkine Jun. 24, 2008
7387271 Immunostimulatory combinations Jun. 17, 2008
7387776 Human monoclonal antibodies against CD30 Jun. 17, 2008
7384633 Human type antihuman IgE receptor antibody and fragment Jun. 10, 2008
7371382 Methods of inhibiting .alpha..sub.v.beta..sub.3-mediated binding with .alpha..sub.v.beta..sub.3-specific antibodies May. 13, 2008
7364734 Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonist Apr. 29, 2008
7361345 Anti-CD40 antibodies capable of blocking B-cell activation Apr. 22, 2008
7361344 Co-administration of a thrombolytic and an-anti-CD18 antibody in stroke Apr. 22, 2008
7345046 Heteroaryl-fused pyrimidinyl compounds as anticancer agents Mar. 18, 2008
7338659 Reducing immunogenicities of immunoglobulins by framework-patching Mar. 4, 2008
7338660 Methods of treating cancer and enhancing immune responses with antibodies that bind CD40 Mar. 4, 2008
7323171 Methods of treating skin conditions using inhibitors of the CD2/LFA-3 interaction Jan. 29, 2008
7323170 Anti-CD80 antibodies Jan. 29, 2008
7321026 Framework-patched immunoglobulins Jan. 22, 2008
7311910 Methods for treating cancer and infectious disease by blocking CTLA4-B7 interactions Dec. 25, 2007
7309489 Mouse CD40 ligand-specific antibodies and hybridomas Dec. 18, 2007
7306800 Treatment of autoimmune disorders with antibodies to costimulating polypeptide of T cells Dec. 11, 2007
7291331 Methods of treating OX40 medicated recall immune responses Nov. 6, 2007
7288251 Antibodies to CD40 Oct. 30, 2007
7288252 Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies Oct. 30, 2007

1 2 3 4 5 6 7 8 9 10 11 12 13










 
 
  Recently Added Patents
Memristive junction with intrinsic rectifier
Adding value to a rendered document
Process for producing .beta.-sialon fluorescent material
6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling
Process for improving the hydrolysis of cellulose in high consistency systems using one or more unmixed and mixed hydrolysis reactors
Inhibitors of bacterial nitric oxide synthase, and related screening methods
Device and process for isolating and cultivating live cells on a filter or extracting their genetic material
  Randomly Featured Patents
Microfluidic devices with monolithic microwave integrated circuits
Instant response broadcast board system and method
Fire board
Hermetic envelope and image display apparatus using the same
Integrated circuit packages including sinuous lead frames
Inhibiting access to a portable storage device
Method for forming interconnect structures for integrated circuits
Method and system for assisting in applying an orthodontic treatment
Video stabilization system and method
.alpha.-Cyano-.beta.-(substituted-anilino)-N-ethoxycarbonylacrylamide intermediates